3-150926972-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000327047.6(CLRN1):c.*964C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00698 in 1,588,004 control chromosomes in the GnomAD database, including 667 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.036 ( 365 hom., cov: 32)
Exomes 𝑓: 0.0039 ( 302 hom. )
Consequence
CLRN1
ENST00000327047.6 3_prime_UTR
ENST00000327047.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.157
Genes affected
CLRN1 (HGNC:12605): (clarin 1) This gene encodes a protein that contains a cytosolic N-terminus, multiple helical transmembrane domains, and an endoplasmic reticulum membrane retention signal, TKGH, in the C-terminus. The encoded protein may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIIa. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 3-150926972-G-A is Benign according to our data. Variant chr3-150926972-G-A is described in ClinVar as [Benign]. Clinvar id is 343800.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-150926972-G-A is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.124 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLRN1 | NM_174878.3 | c.*964C>T | 3_prime_UTR_variant | 3/3 | ENST00000327047.6 | NP_777367.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLRN1 | ENST00000327047.6 | c.*964C>T | 3_prime_UTR_variant | 3/3 | 1 | NM_174878.3 | ENSP00000322280 | P1 | ||
CLRN1 | ENST00000295911.6 | c.343-100C>T | intron_variant | 1 | ENSP00000295911 | |||||
ENST00000469268.1 | n.235+36102G>A | intron_variant, non_coding_transcript_variant | 4 | |||||||
CLRN1-AS1 | ENST00000476886.5 | n.123+74366G>A | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0364 AC: 5535AN: 152096Hom.: 367 Cov.: 32
GnomAD3 genomes
AF:
AC:
5535
AN:
152096
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00985 AC: 2235AN: 226906Hom.: 110 AF XY: 0.00717 AC XY: 873AN XY: 121790
GnomAD3 exomes
AF:
AC:
2235
AN:
226906
Hom.:
AF XY:
AC XY:
873
AN XY:
121790
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00386 AC: 5541AN: 1435790Hom.: 302 Cov.: 26 AF XY: 0.00336 AC XY: 2399AN XY: 714022
GnomAD4 exome
AF:
AC:
5541
AN:
1435790
Hom.:
Cov.:
26
AF XY:
AC XY:
2399
AN XY:
714022
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0364 AC: 5536AN: 152214Hom.: 365 Cov.: 32 AF XY: 0.0347 AC XY: 2580AN XY: 74422
GnomAD4 genome
AF:
AC:
5536
AN:
152214
Hom.:
Cov.:
32
AF XY:
AC XY:
2580
AN XY:
74422
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
22
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 18, 2018 | - - |
Usher syndrome type 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at